Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-18-019852
Filing Date
2018-01-25
Accepted
2018-01-25 16:52:33
Documents
5
Period of Report
2018-03-16
Effectiveness Date
2018-01-25

Document Format Files

Seq Description Document Type Size
1 DEF 14A d502300ddef14a.htm DEF 14A 775105
2 GRAPHIC g502300003.jpg GRAPHIC 11233
3 GRAPHIC g502300graaa.jpg GRAPHIC 20956
4 GRAPHIC g502300img01.jpg GRAPHIC 122715
5 GRAPHIC g502300img02.jpg GRAPHIC 100939
  Complete submission text file 0001193125-18-019852.txt   1129269
Mailing Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101
Business Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101 626-304-3400
ARROWHEAD PHARMACEUTICALS, INC. (Filer) CIK: 0000879407 (see all company filings)

EIN.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: DEF 14A | Act: 34 | File No.: 001-38042 | Film No.: 18548853
SIC: 2834 Pharmaceutical Preparations